Using the Pearson’s chi-square test, there were no statistically significant differences in MTA1 expression among the different groups regarding the clinical variables; patient’s age (P = 0.213), gender (P = 0.176), tumor site (P = 0.702), and the incidence of death (P = 0.105). This evidence concerns the gene MTA1 and neoplasm.